Clinical Research Directory

Inclusion Criteria: * Able to understand and provide written informed consent in English * 18-65 years of age * Informed by primary health care provider that there is no evidence of active disease (this is sometimes referred to as "complete remission" or "cured") * Minimum of 3 months since completion of primary curative-intent cancer therapies including surgery, chemotherapy, radiotherapy, and/or immunotherapy (long-term hormonal therapy permitted) * Onset of fatigue occurred at some point during illness and/or treatment * FACIT-Fatigue scale score in the moderate-to-severe range (i.e., at or above the 60th percentile) * If on any prescription medication (including hormonal therapy), on a stable dose for a minimum of 12 weeks with no plans to change medications or doses during the study Exclusion Criteria: * Taking any short-acting benzodiazepine including midazolam \& triazolam * Known disorder resulting in syncope/fainting during postural changes (e.g., postural orthostatic tachycardia syndrome, orthostatic hypotension) * Pacemaker or known heart condition that influences the electrical or mechanical function of the heart (e.g., severe heart valve disease) * Diagnosed with an externalizing (e.g., substance use, antisocial disorder) or thought (e.g., schizophrenia, paranoid personality, bipolar) disorder that is uncontrolled or untreated * Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability * Currently pregnant * Current litigation related to a physical, health-related injury * Chronic pain rated at least 3/10 on a visual analog scale (VAS)